Last Updated on August 20, 2026 by admin
Sustainability and innovation transformation in the Irish pharma industry.
Sustainability and innovation are moving in parallel and reshaping how life‑sciences companies operate in Ireland. Ireland is famous for being green, but from an energy standpoint, it is green and the direction is clear and measurable: renewables supplied about 41% of Ireland’s electricity in 2023, and 40% in 2024, with wind providing the bulk of that generation. These levels give manufacturers a practical route to lower‑carbon power without stepping away from industrial scale. Our own factories in Dublin are powered by Solar, an initiative we took a few years ago.
Innovation policy is also advancing and is part of the same transformational agenda for Ireland’s Pharmaceutical industry. Ireland’s R&D Tax Credit has recently risen to 35%, a 10% rise since 2023, reinforcing Ireland’s competitiveness and commitment to innovation. Alongside the tax credit, IDA Ireland’s RD&I grants provide additional incentives for companies to invest in R&D, ensuring a major economic support routinely in the range of 45 – 50% support for large-scale, multi-year, innovation project.
Taken together, these shifts amount real change for the pharma industry in Ireland. Cleaner, more sustainable energy that supports large scale industrial development, and a policy framework that rewards innovation, critical enablers for an industry as complex, capital intensive and research focused as the pharmaceutical industry.
Craft are Irelands most trusted packaging manufacturer helping build global brands. Established in 1984 and joining The Asteria Group in 2022 we are based in Dundrum Dublin we are one of Irelands largest self-adhesive label, package and carton manufacturer, supplying to the pharmaceutical, healthcare, medical devices, cosmetic, veterinary and the food and drinks industry.



